Finance

Beta
Lists
POLBF:OTCMKTS
Poolbeg Pharma PLC
$0.10
0.00%
(0.00) 1D
Jun 3, 3:43:40 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for POLBF...
Mkt. cap
58.56M
Avg. vol.
1.40K
Volume
0.00
52-wk high
$0.11
52-wk low
$0.04
Beta
2.10
Shares outstanding
705.10M
No. of employees
15
Mkt. cap
58.56M
Avg. vol.
1.40K
Volume
0.00
52-wk high
$0.11
52-wk low
$0.04
Beta
2.10
Shares outstanding
705.10M
No. of employees
15
News stories
From sources across the web
About Poolbeg Pharma PLC
CEOJeremy Skillington
Employees15
Founded2021
Headquarters-
SectorPharmaceutical industry
Websitepoolbegpharma.com
Previous reportsAll values in GBP
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in GBP
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
263.50K
263.50K
499.00K
499.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.02M
1.02M
1.43M
1.43M
Operating expense
1.17M
1.17M
1.99M
1.99M
Total operating expenses
1.17M
1.17M
1.99M
1.99M
Operating income
-1.17M
-1.17M
-1.99M
-1.99M
Other non operating income
-
-
-
-
EBT including unusual items
-1.12M
-1.12M
-1.77M
-1.77M
EBT excluding unusual items
-1.12M
-1.12M
-1.92M
-1.92M
Income tax expense
-27.50K
-27.50K
-12.00K
-12.00K
Effective tax rate
2.46%
2.46%
0.68%
0.68%
Other operating expenses
-104.50K
-104.50K
61.00K
61.00K
Net income
-1.09M
-1.09M
-1.76M
-1.76M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
58.00K
58.00K
68.50K
68.50K
Interest expense
-
-
-
-
Net interest expenses
58.00K
58.00K
68.50K
68.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.16M
-1.16M
-1.97M
-1.97M
Gain or loss from assets sale
-
-
2.50K
2.50K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer